Pacific Edge says US medical and legal tides have turned in its favour

Pacific Edge says US medical and legal tides have turned in its favour
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge is confident its newly announced $20 million capital raise, combined with new research results and professional validation, will keep it in the bladder cancer testing game.Chief executive Peter Meintjes says a clinical endorsement from the American Urological Association (AUA) should give it the medical and legal clout to regain Medicare coverage for its bladder cancer tests in the US.The dual NZX and ASX-listed medical technology company reported a net loss of $29.9m in the 12 months to March 31, 2025, compared with $29.5m in the...

More Markets

NZ sharemarket rises strongly on power company gains
Markets Market Close

NZ sharemarket rises strongly on power company gains

Positive day for Mercury and Meridian as well as a2 Milk despite gloom on global front. 

Inside Ebos’s ‘revolutionary’ $1.1 billion deal
Markets

Inside Ebos’s ‘revolutionary’ $1.1 billion deal

In 2013, Ebos swallowed a giant. Now it’s the end of an era.

Analysts eye upside in property sector as values stabilise
Property

Analysts eye upside in property sector as values stabilise

On average, listed property companies are trading at a 22% discount to NTA.

Why MCK’s failed takeover lost Sharesies a customer
Markets

Why MCK’s failed takeover lost Sharesies a customer

This former Sharesies user made bank on MCK, but is leaving the platform anyway.